Ingolf Lachmann

1.7k total citations
47 papers, 1.1k citations indexed

About

Ingolf Lachmann is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Ingolf Lachmann has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 16 papers in Molecular Biology and 16 papers in Neurology. Recurrent topics in Ingolf Lachmann's work include Parkinson's Disease Mechanisms and Treatments (16 papers), Alzheimer's disease research and treatments (15 papers) and Neurological diseases and metabolism (5 papers). Ingolf Lachmann is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (16 papers), Alzheimer's disease research and treatments (15 papers) and Neurological diseases and metabolism (5 papers). Ingolf Lachmann collaborates with scholars based in Germany, United States and United Kingdom. Ingolf Lachmann's co-authors include Thomas Mothes, Partha S. Mukherjee, Lilian Calderón‐Garcidueñas, Katharina Waniek, Herbert Budka, Gábor G. Kovács, Ricardo Torres‐Jardón, Franka Kahlenberg, Daniel Sánchez and Ludmila Tučková and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and International Journal of Molecular Sciences.

In The Last Decade

Ingolf Lachmann

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingolf Lachmann Germany 18 440 324 242 188 173 47 1.1k
Jinbiao Zhang China 19 188 0.4× 146 0.5× 336 1.4× 180 1.0× 17 0.1× 54 991
François Cossais Germany 19 152 0.3× 106 0.3× 279 1.2× 101 0.5× 15 0.1× 40 847
Beibei Cao China 21 151 0.3× 98 0.3× 528 2.2× 295 1.6× 36 0.2× 69 1.4k
Eduardo Agüera Spain 20 82 0.2× 130 0.4× 370 1.5× 197 1.0× 61 0.4× 62 1.4k
Gunjan D. Manocha United States 14 43 0.1× 198 0.6× 172 0.7× 158 0.8× 43 0.2× 23 544
Hong Sun China 18 92 0.2× 65 0.2× 198 0.8× 214 1.1× 58 0.3× 53 884
Esther Eberhardt Germany 11 178 0.4× 178 0.5× 370 1.5× 149 0.8× 46 0.3× 14 765
Yang Xiang China 18 156 0.4× 411 1.3× 270 1.1× 201 1.1× 9 0.1× 55 995

Countries citing papers authored by Ingolf Lachmann

Since Specialization
Citations

This map shows the geographic impact of Ingolf Lachmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingolf Lachmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingolf Lachmann more than expected).

Fields of papers citing papers by Ingolf Lachmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingolf Lachmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingolf Lachmann. The network helps show where Ingolf Lachmann may publish in the future.

Co-authorship network of co-authors of Ingolf Lachmann

This figure shows the co-authorship network connecting the top 25 collaborators of Ingolf Lachmann. A scholar is included among the top collaborators of Ingolf Lachmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingolf Lachmann. Ingolf Lachmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klafki, Hans‐Wolfgang, Chris Bauer, Andreas Steiert, et al.. (2025). Evaluation of a fully automated assay for the measurement of plasma pTau217 and a composite score integrating the ratio Aβ1-42/1-40 as biomarkers of Alzheimer’s disease. European Archives of Psychiatry and Clinical Neuroscience.
2.
3.
Klafki, Hans‐Wolfgang, Chris Bauer, Katharina Waniek, et al.. (2024). Assessment of immunoprecipitation with subsequent immunoassays for the blood-based diagnosis of Alzheimer’s disease. European Archives of Psychiatry and Clinical Neuroscience. 275(8). 2215–2227. 3 indexed citations
4.
Lerche, Stefanie, Milan Zimmermann, Benjamin Röeben, et al.. (2023). Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD. npj Parkinson s Disease. 9(1). 38–38. 14 indexed citations
5.
Lerche, Stefanie, Simon Sjödin, Ann Brinkmalm, et al.. (2021). CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB. Movement Disorders. 36(11). 2595–2604. 16 indexed citations
6.
Lachmann, Ingolf, et al.. (2020). Aggrecan modulates the expression and phosphorylation of tau in a novel bigenic TauP301L ‐ Acan mouse model. European Journal of Neuroscience. 53(12). 3889–3904. 7 indexed citations
7.
Bousiges, Olivier, Nathalie Philippi, Thomas Lavaux, et al.. (2020). Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer’s disease and dementia with Lewy bodies from the prodromal stage. Alzheimer s Research & Therapy. 12(1). 120–120. 20 indexed citations
8.
Vallabh, Sonia M., Eric Vallabh Minikel, Victoria J. Williams, et al.. (2020). Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease. BMC Medicine. 18(1). 140–140. 29 indexed citations
9.
Bauer, Chris, Johannes Schuchhardt, Dirk Wedekind, et al.. (2019). Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer’s disease. Journal of Neural Transmission. 126(3). 339–348. 18 indexed citations
10.
Llorens, Franc, Anna Villar‐Piqué, Péter Hermann, et al.. (2019). Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt–Jakob disease: a comparative prospective study with 14-3-3. Journal of Neurology. 267(2). 543–550. 7 indexed citations
11.
Calderón‐Garcidueñas, Lilian, Partha S. Mukherjee, Katharina Waniek, et al.. (2018). Non-Phosphorylated Tau in Cerebrospinal Fluid is a Marker of Alzheimer’s Disease Continuum in Young Urbanites Exposed to Air Pollution. Journal of Alzheimer s Disease. 66(4). 1437–1451. 27 indexed citations
12.
Llorens, Franc, Angela da Silva Correia, Anna Villar‐Piqué, et al.. (2018). Cerebrospinal Fluid Prion Disease Biomarkers in Pre-clinical and Clinical Naturally Occurring Scrapie. Molecular Neurobiology. 55(11). 8586–8591. 17 indexed citations
13.
Santos, Márcia Cristina Teixeira dos, D. Scheller, Claudia Schulte, et al.. (2018). Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson’s disease diagnosis. PLoS ONE. 13(11). e0206536–e0206536. 34 indexed citations
14.
Bétemps, Dominique, Jérémy Verchère, Ingolf Lachmann, et al.. (2015). Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein. Journal of Visualized Experiments. e52752–e52752. 2 indexed citations
15.
Arsalan-Werner, Annika, Isabel Hilbrich, Carsten Jäger, et al.. (2015). Hook Proteins: Association with Alzheimer Pathology and Regulatory Role of Hook3 in Amyloid Beta Generation. PLoS ONE. 10(3). e0119423–e0119423. 18 indexed citations
16.
Unterberger, Ursula, Ingolf Lachmann, Till Voigtländer, et al.. (2014). Detection of disease-associated α-synuclein in the cerebrospinal fluid: a feasibility study. Clinical Neuropathology. 33(9). 329–334. 16 indexed citations
17.
Kovács, Gábor G., Uta Wagner, Benoît Dumont, et al.. (2012). An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology. Acta Neuropathologica. 124(1). 37–50. 124 indexed citations
18.
Wolf, Johannes, Ingolf Lachmann, Uta Wagner, Awad A. Osman, & Thomas Mothes. (2011). Quantification of human tissue transglutaminase by a luminescence sandwich enzyme-linked immunosorbent assay. Analytical Biochemistry. 419(2). 153–160. 10 indexed citations
19.
Wolf, Johannes, Ingolf Lachmann, Uta Wagner, Awad A. Osman, & Thomas Mothes. (2010). Immunoassay of in vitro activated human tissue transglutaminase. Analytical Biochemistry. 411(1). 10–15. 3 indexed citations
20.
Philipp, W., Darlene Groth, Kurt Giles, et al.. (2007). Transgenic mouse brains for the evaluation and quality control of BSE tests. Biological Chemistry. 388(3). 349–354. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinbiao Zhang Breakdown of academic impact, for papers by François Cossais Breakdown of academic impact, for papers by Beibei Cao Breakdown of academic impact, for papers by Eduardo Agüera Breakdown of academic impact, for papers by Gunjan D. Manocha Breakdown of academic impact, for papers by Hong Sun Breakdown of academic impact, for papers by Esther Eberhardt Breakdown of academic impact, for papers by Yang Xiang
Rankless by CCL
2026